XML 41 R29.htm IDEA: XBRL DOCUMENT v3.22.2
Description of Business and Organization - Additional Information (Detail) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 6 Months Ended
Jun. 01, 2021
May 23, 2021
Jun. 30, 2021
Jun. 30, 2022
Dec. 31, 2021
Organization Consolidation And Presentation Of Financial Statements [Line Items]          
Proceeds from issuance of initial public offering $ 167,000        
Payments of stock issuance costs $ 17,000        
Share-based compensation arrangement by share-based payment award, options, vested, number of shares       4,719,605  
Common stock shares authorized       500,000,000 500,000,000
Preferred stock shares authorized       10,000,000  
Common stock par or stated value per share       $ 0.0001 $ 0.0001
Preferred stock par or stated value per share       $ 0.0001  
Stockholders' equity note, stock split   2.325-for-1      
Retained Earnings (Accumulated Deficit)       $ (191,764) $ (127,487)
Cash and cash equivalents       $ 388,877 $ 284,309
IPO [Member]          
Organization Consolidation And Presentation Of Financial Statements [Line Items]          
Common stock issued in IPO, net of issuance costs of $16,995 (In shares) 11,500,000   11,500,000    
Shares issued, price per share $ 16.00     $ 16.00  
Number of shares issued upon conversion       5,433,290  
Stock issued during period, shares, conversion of units       32,489,398  
Share-based compensation arrangement by share-based payment award, options, grants in period, net of forfeitures       4,418,874  
Over-Allotment Option [Member]          
Organization Consolidation And Presentation Of Financial Statements [Line Items]          
Stock issued during period, shares, issued for services 1,500,000        
Series A Redeemable Convertible Preferred Stock [Member]          
Organization Consolidation And Presentation Of Financial Statements [Line Items]          
Common stock par or stated value per share       $ 0.0001  
Series A Redeemable Convertible Preferred Stock [Member] | Millennium Pharmaceuticals, Inc. [Member] | The Millennium Stock Exchange Agreement [Member]          
Organization Consolidation And Presentation Of Financial Statements [Line Items]          
Conversion of stock, shares converted       9,857,143  
Convertible preferred stock, shares issued upon conversion       6,470,382